Australian Drug Maker Has Low Profile but Powerful Backers in Washington

By KATIE THOMAS from NYT Health http://ift.tt/2jhORMb
via IFTTT
Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.
Australian Drug Maker Has Low Profile but Powerful Backers in Washington - By KATIE THOMAS - at Health - Keyword: United States Politics and Government, Drugs (Pharmaceuticals) - From The New York Times - Published at January 13, 2017 at 07:00AM